Becton Dickinson and Company (BDX) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.028x

Based on the latest financial reports, Becton Dickinson and Company (BDX) has a cash flow conversion efficiency ratio of 0.028x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($671.00 Million) by net assets ($24.13 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Becton Dickinson and Company (BDX) defensive interval to measure how many days the company can operate on defensive assets alone.

Becton Dickinson and Company - Cash Flow Conversion Efficiency Trend (1989–2025)

This chart illustrates how Becton Dickinson and Company's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Becton Dickinson and Company Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Becton Dickinson and Company ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
ArcelorMittal SA
MC:MTS
0.000x
China CSSC Holdings Ltd
SHG:600150
0.014x
ArcelorMittal SA
XETRA:ARRD
0.000x
Mahindra & Mahindra Limited
NSE:M&M
0.000x
Ventas Inc
NYSE:VTR
0.030x
Deutsche Börse AG
XETRA:DB1
0.124x
ITC Limited
NSE:ITC
0.085x
Haleon plc
NYSE:HLN
0.090x

Annual Cash Flow Conversion Efficiency for Becton Dickinson and Company (1989–2025)

The table below shows the annual cash flow conversion efficiency of Becton Dickinson and Company from 1989 to 2025. For the full company profile with market capitalisation and key ratios, see BDX market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-09-30 $25.39 Billion $3.43 Billion 0.135x -7.91%
2024-09-30 $25.89 Billion $3.80 Billion 0.147x +26.61%
2023-09-30 $25.80 Billion $2.99 Billion 0.116x +11.25%
2022-09-30 $25.28 Billion $2.63 Billion 0.104x -46.94%
2021-09-30 $23.68 Billion $4.65 Billion 0.196x +31.80%
2020-09-30 $23.77 Billion $3.54 Billion 0.149x -5.38%
2019-09-30 $21.16 Billion $3.33 Billion 0.157x +15.32%
2018-09-30 $20.99 Billion $2.87 Billion 0.136x -30.71%
2017-09-30 $12.95 Billion $2.55 Billion 0.197x -41.25%
2016-09-30 $7.63 Billion $2.56 Billion 0.335x +45.54%
2015-09-30 $7.51 Billion $1.73 Billion 0.230x -33.27%
2014-09-30 $5.05 Billion $1.74 Billion 0.345x +15.47%
2013-09-30 $5.04 Billion $1.51 Billion 0.299x -29.77%
2012-09-30 $4.14 Billion $1.76 Billion 0.426x +19.75%
2011-09-30 $4.83 Billion $1.72 Billion 0.355x +10.74%
2010-09-30 $5.43 Billion $1.74 Billion 0.321x -3.86%
2009-09-30 $5.14 Billion $1.72 Billion 0.334x -2.34%
2008-09-30 $4.94 Billion $1.69 Billion 0.342x +20.20%
2007-09-30 $4.36 Billion $1.24 Billion 0.284x +1.35%
2006-09-30 $3.84 Billion $1.08 Billion 0.281x -26.24%
2005-09-30 $3.22 Billion $1.23 Billion 0.380x +6.34%
2004-09-30 $3.07 Billion $1.10 Billion 0.358x +14.43%
2003-09-30 $2.90 Billion $905.70 Million 0.313x -6.96%
2002-09-30 $2.49 Billion $836.03 Million 0.336x +0.50%
2001-09-30 $2.33 Billion $778.64 Million 0.334x +6.26%
2000-09-30 $1.96 Billion $615.49 Million 0.315x +28.89%
1999-09-30 $1.77 Billion $431.80 Million 0.244x -21.33%
1998-09-30 $1.61 Billion $500.80 Million 0.310x -2.89%
1997-09-30 $1.39 Billion $442.70 Million 0.320x -8.02%
1996-09-30 $1.33 Billion $460.40 Million 0.347x +2.89%
1995-09-30 $1.40 Billion $472.20 Million 0.338x +4.34%
1994-09-30 $1.48 Billion $479.50 Million 0.324x +47.43%
1993-09-30 $1.46 Billion $319.80 Million 0.220x +13.59%
1992-09-30 $1.59 Billion $308.20 Million 0.193x +3.72%
1991-09-30 $1.36 Billion $254.10 Million 0.186x -11.26%
1990-09-30 $1.23 Billion $259.00 Million 0.210x +53.14%
1989-09-30 $1.07 Billion $146.90 Million 0.137x --

About Becton Dickinson and Company

NYSE:BDX USA Medical Instruments & Supplies
Market Cap
$39.67 Billion
Market Cap Rank
#688 Global
#317 in USA
Share Price
$143.98
Change (1 day)
+1.67%
52-Week Range
$141.61 - $210.02
All Time High
$278.09
About

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segme… Read more